首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece.
【24h】

Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece.

机译:希腊社区获得性尿路感染引起的大肠杆菌菌株对喹诺酮的耐药性。

获取原文
获取原文并翻译 | 示例
           

摘要

Susceptibility data for 10 049 Escherichia coli isolates derived from community-acquired urinary tract infections in Greece during the period January 2000 to June 2002 indicated 8.1% resistance to nalidixic acid and 36% resistance to ciprofloxacin. In a sample of 170 E. coli isolates, mutations in gyrA (25 isolates) and parC (15 isolates) were consistent with the levels of resistance to quinolones. Previous exposure to quinolones and underlying chronic disease were independent risk factors for infection by quinolone-resistant E. coli strains.
机译:在2000年1月至2002年6月期间,来自希腊社区获得性泌尿道感染的10 049株大肠杆菌分离株的药敏性数据显示,耐萘啶酸的抗药性为8.1%,环丙沙星的抗药性为36%。在170个大肠杆菌分离株的样本中,gyrA(25个分离株)和parC(15个分离株)中的突变与对喹诺酮类药物的耐药水平一致。先前接触喹诺酮类药物和潜在的慢性疾病是耐喹诺酮类大肠杆菌菌株感染的独立危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号